Amount Raised
$45 Million
Round Type
Series B
Investors
Description
Arrivo BioVentures today announced the closing of an oversubscribed Series B preferred financing round, totaling $45.25 million in committed capital, bringing the total raised since the company’s inception to $100M.
Quick answer
ArrivoBio raised $45 Million in a Series B round, dated November 29, 2023. Investors: Arrivo, Rex Health Ventures, Solas Bio Ventures Emerging Healthcare Fund, L.P. and Orlando Health Ventures. ArrivoBio is based in Morrisville, New York, United States.
- How much did ArrivoBio raise?
- ArrivoBio raised $45 Million in a Series B round on November 29, 2023.
- Who invested in ArrivoBio?
- Arrivo, Rex Health Ventures, Solas Bio Ventures Emerging Healthcare Fund, L.P. and Orlando Health Ventures are named as investors in this round.
- What does ArrivoBio do?
- SP-624 is a small molecule that selectively activates the SIRT6 enzyme, a novel epigenetic mechanism known to modulate gene expression, metabolism and DNA repair.
- Where is ArrivoBio based and how big is it?
- ArrivoBio is based in Morrisville, New York, United States.
- Who are the decision-makers at ArrivoBio?
- Fundz holds 1 contact at ArrivoBio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ArrivoBio that raised within 45 days of this round, from Fundz verified event records.
- Gallant raised $15M (Series A) on January 8, 2024.
- Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
- Liquidia raised $100M (Funding Round) on January 4, 2024.
- OnCusp Therapeutics raised $100M (Series A) on January 4, 2024.
- Voyager Therapeutics raised $20M on January 3, 2024.
- Alpha Cognition raised $1.8M (Seed) on December 22, 2023.
Who to call at ArrivoBio, and when
A new round usually means ArrivoBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ArrivoBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ArrivoBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ArrivoBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ArrivoBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansArrivoBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.